Home

SAN DIEGO (Reuters) - Scientists have for the first time created blood platelet cells by reprogramming stem cells derived from adult cells, offering the potential for a renewable supply of the fragile blood component.

Researchers at the Center for iPS Cell Research and Application at Kyoto University in Japan presented data at a meeting of the American Society of Hematology showing ...

(Reuters) - A rogue surgeon injects stem cells from a fetus into a sick man's brain. The cells morph and form body parts. When the man dies, the pathologist finds cartilage, skin and bone clumped in his brain.

The scene is not from a horror movie; it happened to Max Truex, a former Olympic runner who suffered from Parkinson's ...

The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs, and the company will focus instead on new cancer treatments, Geron said Tuesday.

The California-based biotech firm, which had bypassed federal funding to get its pioneering but controversial trial off the ground in October 2010, said it was also cutting 66 ...

LONDON (Reuters) - A decision by one of the biggest names in stem cell research to throw in the towel will not stop other pioneering work that could yet produce cures for blindness and help mend broken hearts.

Scientists were shocked by U.S. biotech company Geron Corp's decision on Monday to quit embryonic stem cell research -- a move it ...

LUXEMBOURG (Reuters) - European law forbids patenting any process which involves removing a stem cell from and then destroying a human embryo, Europe's top court ruled on Tuesday, a judgment with deep ramifications on medical research.

The ruling by the European Court of Justice concerned a method invented by Oliver Bruestle of the University of Bonn for converting human embryonic ...

LONDON (Reuters) - British scientists have developed a new stem cell technique for growing working liver cells which could eventually avoid the need for costly and risky liver transplants.

A team of researchers led by the Sanger Institute and the University of Cambridge used cutting-edge methods to correct a genetic mutation in stem cells derived from a patient's skin biopsy ...

Scientists on Wednesday said they had made strides in lab research in personalised stem cells, reviving interest in a goal clouded by fraud and ethical storms.

Stem cells are primitive cells that differentiate into the various tissues of the body and are touted as future replacements for diseased or damaged organs.

The idea is to take versatile stem cells from ...

CHICAGO (Reuters) - U.S. scientists for the first time have used a cloning technique to get tailor-made embryonic stem cells to grow in unfertilized human egg cells, a landmark finding and a potential new flashpoint for opponents of stem cell research.

The researchers were trying to prove it is possible to use a cloning technology called somatic cell nuclear transfer ...

LONDON (Reuters) - British drug regulators have granted approval to Advanced Cell Technology to conduct the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness, the firm said on Thursday.

Massachusetts-based ACT will start the trial of its treatment, which uses retinal pigment epithelium derived from human embryonic stem ...

A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.

The Massachusetts-based Advanced Cell Technology said the trials will involve 12 patients with Stargardt's disease and will be based at Moorfields Eye Hospital in London, with more ...